Literature DB >> 3437790

[Prognostic criteria of papillary thyroid cancer. Morphologic clinical analysis of 202 cases of tumor].

S Schröder1, H Dralle, W Rehpenning, W Böcker.   

Abstract

A retrospective study of 202 papillary thyroid carcinomas was conducted to determine the prognostic value of different morphological and clinical features. The biological behaviour was primarily influenced by tumor type: Among encapsulated (n = 28) and occult lesions (n = 34), each time recurrence-free survival was seen, whereas 22% of patients with widely invasive tumours (n = 140) died from carcinoma (mean observation period: 9.6 years). In the latter group, dismal prognosis was demonstrated for older patients (greater than 52 years) and oxyphilic or poorly differentiated tumours; the same effect was shown for presence of distant haematogenous spread and tumour invasion of cervical soft tissue. Since lethal outcome was seen even in cases lacking the aforenamed unfavourable criteria, total thyroidectomy should be performed for all widely invasive neoplasms regardless of cellular or histological differentiation, stage of disease and age at diagnosis. The same applies for the two prognostically excellent subtypes in the case of regional metastases. As opposed to this, hemithyroidectomy and life-long TSH-suppressive oral hormone replacement therapy is regarded to be sufficient in encapsulated and occult papillary tumours not accompanied by regional or distant metastases.

Entities:  

Mesh:

Year:  1987        PMID: 3437790     DOI: 10.1007/BF01258974

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  48 in total

1.  THYROID CARCINOMA AND DEATH. A CLINICOPATHOLOGICAL STUDY OF 193 AUTOPSIES.

Authors:  W M SILLIPHANT; G H KLINCK; M S LEVITIN
Journal:  Cancer       Date:  1964-04       Impact factor: 6.860

2.  [Morphology and prognosis of anaplastic thyroid cancer].

Authors:  S Schröder; C Bürk; H Dralle; W Rehpenning; W Böcker
Journal:  Pathologe       Date:  1987-03       Impact factor: 1.011

3.  Selection of surgical treatment for well differentiated thyroid carcinomas.

Authors:  J A Buckwalter; C G Thomas
Journal:  Ann Surg       Date:  1972-10       Impact factor: 12.969

4.  Papillary carcinoma of the thyroid. II. Value of prophylactic lymph node excision.

Authors:  S Noguchi; A Noguchi; N Murakami
Journal:  Cancer       Date:  1970-11       Impact factor: 6.860

5.  The encapsulated follicular carcinoma of the thyroid. A clinicopathologic study of 35 cases.

Authors:  S Schröder; N Pfannschmidt; H Dralle; H Arps; W Böcker
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

6.  [Differentiated thyroid carcinoma in an endemic area. Clinical aspects, prognosis, therapeutic considerations].

Authors:  D Ladurner; G Seeber; F Hofstädter; W Zechmann
Journal:  Dtsch Med Wochenschr       Date:  1985-03-01       Impact factor: 0.628

7.  The encapsulated papillary carcinoma of the thyroid. A morphologic subtype of the papillary thyroid carcinoma.

Authors:  S Schröder; W Böcker; H Dralle; K B Kortmann; C Stern
Journal:  Cancer       Date:  1984-07-01       Impact factor: 6.860

8.  Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases.

Authors:  N A Samaan; Y K Maheshwari; S Nader; C S Hill; P N Schultz; T P Haynie; R C Hickey; R L Clark; H Goepfert; M L Ibanez; C E Litton
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

9.  Risk factor analysis in differentiated thyroid cancer.

Authors:  B Cady; C E Sedgwick; W A Meissner; M S Wool; F A Salzman; J Werber
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

10.  Papillary carcinoma of the thyroid gland.

Authors:  R R Baker; J Hyland
Journal:  Surg Gynecol Obstet       Date:  1985-12
View more
  6 in total

1.  Encapsulated papillary thyroid carcinoma: is it a distinctive clinical entity with low-grade malignancy?

Authors:  A Pisanu; D Deplano; I Reccia; G Porceddu; A Uccheddu
Journal:  J Endocrinol Invest       Date:  2012-01-31       Impact factor: 4.256

2.  Recurrent differentiated thyroid cancer: to cut or burn.

Authors:  Roberto Cirocchi; Stefano Trastulli; Alessandro Sanguinetti; Lorenzo Cattorini; Piero Covarelli; Domenico Giannotti; Giorgio Di Rocco; Fabio Rondelli; Francesco Barberini; Carlo Boselli; Alberto Santoro; Nino Gullà; Adriano Redler; Nicola Avenia
Journal:  World J Surg Oncol       Date:  2011-08-12       Impact factor: 2.754

Review 3.  Predictors of thyroid tumor aggressiveness.

Authors:  O H Clark
Journal:  West J Med       Date:  1996-09

4.  Diffuse sclerosing variant of papillary thyroid carcinoma. S-100 protein immunocytochemistry and prognosis.

Authors:  S Schröder; V Bay; K Dumke; B Kremens; H W Müller-Gärtner; W Böcker; H Kastendieck
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

5.  [Initial results of image cytometric DNA analysis in the evaluation of prognosis in papillary thyroid cancer].

Authors:  T Böttger; H Gabbert; M Stöckle; B Schernos; T Junginger
Journal:  Langenbecks Arch Chir       Date:  1991

6.  Hürthle cell (oxyphilic) papillary thyroid carcinoma: a variant with more aggressive biologic behavior.

Authors:  M F Herrera; I D Hay; P S Wu; J R Goellner; J J Ryan; J R Ebersold; E J Bergstralh; C S Grant
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.